[Advances in Pharmacology] Current Challenges in Personalized Cancer Medicine Volume 65 || Apoptosis In Targeted Therapy Responses

[Advances in Pharmacology] Current Chall

[Advances in Pharmacology] Current Challenges in Personalized Cancer Medicine Volume 65 || Targeted Therapy for Gastric Adenocarcinoma

✍ Almhanna, Khaldoun 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 294 KB

For this volume of Advances in Pharmacology we have brought together some of the foremost basic science and clinical researchers to discuss some of the new frontiers in the development of targeted cancer therapy. Although still in its formative stages, the development of targeted cancer therapies ha

[Advances in Pharmacology] Current Chall

[Advances in Pharmacology] Current Challenges in Personalized Cancer Medicine Volume 65 || Vertical Pathway Targeting in Cancer Therapy

✍ Shahbazian, David 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 683 KB

[Advances in Pharmacology] Current Chall

[Advances in Pharmacology] Current Challenges in Personalized Cancer Medicine Volume 65 || Resistance to Chemotherapy

✍ Basile, Kevin J. 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 321 KB

[Advances in Pharmacology] Current Chall

[Advances in Pharmacology] Current Challenges in Personalized Cancer Medicine Volume 65 || Targeting Notch Signaling for Cancer Therapeutic Intervention

✍ Shao, Hongwei 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 1023 KB

For this volume of Advances in Pharmacology we have brought together some of the foremost basic science and clinical researchers to discuss some of the new frontiers in the development of targeted cancer therapy. Although still in its formative stages, the development of targeted cancer therapies ha

[Advances in Pharmacology] Current Chall

[Advances in Pharmacology] Current Challenges in Personalized Cancer Medicine Volume 65 || Targeting the Metabolic Microenvironment of Tumors

✍ Bailey, Kate M. 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 569 KB

For this volume of Advances in Pharmacology we have brought together some of the foremost basic science and clinical researchers to discuss some of the new frontiers in the development of targeted cancer therapy. Although still in its formative stages, the development of targeted cancer therapies ha

[Advances in Pharmacology] Current Chall

[Advances in Pharmacology] Current Challenges in Personalized Cancer Medicine Volume 65 || HSP90 Inhibitors for Cancer Therapy and Overcoming Drug Resistance

✍ Jhaveri, Komal 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 451 KB